INVESTIGATION OF CRITICAL MATERIAL ATTRIBUTES OF NANOCELLULOSE IN TABLETS

ROSHNI VORA; YAMINI SHAH

doi:10.22159/ajpcr.2019.v12i7.33725

Authors

ROSHNI VORA Department of Pharmaceutics and Pharmaceutical Technology, L. M. College of Pharmacy, Ahmedabad, Gujarat, India.
YAMINI SHAH Department of Pharmaceutics and Pharmaceutical Technology, L. M. College of Pharmacy, Ahmedabad, Gujarat, India.

DOI:

https://doi.org/10.22159/ajpcr.2019.v12i7.33725

Keywords:

Microcrystalline cellulose (MCC PH200),, Nano cellulose (AH-NC),, Novel excipient,, I-optimal design,, Powder flow properties

Abstract

Objective: The present work aims to compare powder flow properties and post-compression characteristics of acid hydrolysis nanocellulose (AH-NC) a novel excipient with microcrystalline cellulose (MCC PH200) to demonstrate the application and performance of AH-NC.

Methods: I-optimal design was applied separately for both the excipient, i.e., MCC PH200 and AH-NC. Independent variables were MCC PH200 as diluent (X1), AH-NC as diluent (X1), starch as disintegrant (X2), and PVP K30 as dry binder (X3). The dependent variables in design were Carr’s index (CI) (R1), angle of repose (AR) (R2), hardness (R3), friability (R4), disintegration time (DT) (R5), and T90 (R6).

Results: Fourier-transform infrared spectroscopy (FTIR) and differential scanning calorimetry studies showed the compatibility of the drug with an excipient. CI was found in the range of 8%–17.84% for MCC PH200 and 5.25%–11.94% for AH-NC. AR was found in the range of 31.48–37.66 for MCC PH200 and 29.62–35.30 for AH-NC. The values of friability, DT, and T90 were almost identical in both the cases.

Conclusion: Not only does AH-NC demonstrates better flow properties but also problems of weight variation and content uniformity are not observed when compared to MCC PH200. Hence, AH-NC is more suitable as an excipient for modern high-speed rotary tablet press.

Downloads

Download data is not yet available.

References

Siro I, Plackett D. Microfibrillated cellulose and new nanocomposite materials: A review. Cellulose 2010;17:459-94.

Peng BL, Dhar N, Liu HL, Tam KC. Chemistry and applications of nanocrystalline cellulose and its derivatives: A nanotechnology perspective. Can J Chem Eng 2011;89:1191-206.

Rajinipriya M, Nagalakshmaiah M, Robert M, Elkoun S. Importance of agricultural and industrial waste in the field of nanocellulose and recent industrial developments of wood based nanocellulose: A review. ACS Sustain Chem Eng 2018;6:2807-28.

TAPPI. Summary of International Activities on Cellulosic Nanomaterials Conference: 2015.

Zimmermann T, Pohler E, Geiger T. Cellulose fibrils for polymer reinforcement. Adv Eng Mater 2004;6:754-61.

Lu J, Wang T, Drzal LT. Preparation and properties of microfibrillated cellulose polyvinyl alcohol composite materials. Compos Part A 2008;39:738-46.

Nakagaito AN, Fujimura A, Sakai T, Hama Y, Yano H. Production of microfibrillated cellulose (MFC)-reinforced polylactic acid (PLA) nanocomposites from sheets obtained by a papermaking-like process. Compos Sci Technol 2009;69:1293-7.

Gabr MH, Elrahman MA, Okubo K, Fujii T. Effect of microfibrillated cellulose on mechanical properties of plain-woven CFRP reinforced epoxy. Compos Struct 2010;92:1999-2006.

Gandhi TP. Sulphonylureas second generation drugs. Indian Drugs 1978;6:163-5.

Balagani PK, Irisappan SC, Korlakunta NJ. Formulation development and evaluation of glibenclamide loaded eudragit RLPO microparticles. Int Curr Pharm J 2013;2:196-201.

Mohammed A, Mohd A, Abdul A, Abul KN, Yasmin S, Asgar A. Application of box-behnken design for preparation of glibenclamide loaded lipid based nanoparticles: Optimization, in vitro skin permeation, drug release and in vivo pharmacokinetic study. J Mol Liq 2016;219:897-908.

Food and Drug Administration. Quality by Design for ANDAS: An Example for Immediate-Release Dosage United States: Food and Drug Administration; 2015.

Nasr M, Migliaccio G, Allen B, Baum R. FDA’s pharmaceutical quality initiatives. Pharm Tech 2008;32:54-72.

Kumar BS, Saraswathi R, Kumar KV, Jha SK, Venkates DP, Dhanaraj SA, et al. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery. Drug Deliv 2014;21:173-84.

Guan J, Han J, Zhang D, Chu C, Liu H, Sun J, et al. Increased dissolution rate and oral bioavailability of hydrophobic drug glyburide tablets produced using supercritical CO2 silica dispersion technology. Eur J Pharm Biopharm 2014;86:376-82.

Jeevana JB, Mounika M. Assessment of self-extracted cellulose from oryza sativa for design of controlled drug delivery system of dalfampridine. Asian J Pharm Clin Res 2019;12:338-45.

Mura P, Furlanetto S, Cirri M, Maestrelli F, Marras AM, Pinzauti S, et al. Optimization of glibenclamide tablet composition through the combined use of differential scanning calorimetry and D-optimal mixture experimental design. J Pharm Biomed Anal 2005;37:65-71.

The United State Pharmacopoeia (USP), National Formulary. Rockville, MD, USA: United State Pharmacopeial Convention; 2011.

Hausner H. Friction conditions in a mass of metal powder. Int J Powder Metall 1967;3:7-13.

Jaya S, Divya S. Formulation and in vitro evaluation of matrix tablets of metoclopramide hydrochloride. Int J Appl Pharm 2019;11:25-30.

Lachman L, Libermann HA, Kanig JL. The Theory and Practice of Industrial Pharmacy. 3rd ed. Philadelphia (USA): Bombay: Varghese Publisher House; 1991. p. 297-303.

Amrita S, Vaibhav R, Varsha K. Formulation development and evaluation of fast dissolving tablet of ramipril. Int J Pharm Pharm Sci 2015;7:127-31.

Nawal AR, Mohammad SJ, Formulation and in vitro evaluation of piroxicam microsponge as a tablet. Int J Pharm Pharm Sci 2016;8:104-14.

The United State Pharmacopoeia (USP), National Formulary. Rockville, Md, USA: United State Pharmacopeial Convention; 2000.